NF2 and meningioma: Dual blockade of mTORC1/2 and IGF1R/insulin signaling effectively reduced pAkt T308 and cell viability, supporting co-inhibition as a potential therapeutic strategy in NF2-deficient meningiomas (Beauchamp et al., 2021).